scleroderma and ulcers Archives - ACR Meeting Abstracts

Abstract Number: 2706 • ACR/ARHP Annual Meeting 2018
Discriminant Validity and Reliability of World Scleroderma Foundation (WSF) Definition of Skin Ulcers in Systemic Sclerosis
Yossra A Suliman¹, Cosimo Bruni², Sindhu Johnson³, Suzanne Kafaja⁴, Emanuela Praino⁵, Dinesh Khanna⁶, Yannick Allanore⁷, Murray Baron⁸, Jonathan Grotts⁹, Thomas Krieg¹⁰, Ariane L. Herrick¹¹, Christopher P. Denton¹², Marco Matucci-Cerinic¹³ and Daniel E. Furst¹⁴, ¹Rheumatology and Rehabilitation dept., Rheumatology and Rehabilitation dept. Assiut university hospital, Assiut Egypt, Assiut, Egypt, ²Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Firenze, Italy, ³Toronto Scleroderma Program, Toronto Western Hospital, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ⁴David Geffen School of Medicine, UCLA, Los Angeles, CA, ⁵DIM, Rheumatology Unit - D.E.T.O. - University of Bari (ITALY), Bari, Italy, ⁶Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, ⁷Service de Rhumatologie A, Hôpital Cochin, Paris, France, ⁸Rheumatology, Jewish General Hospital, Montreal, QC, Canada, ⁹Biostatistics, University of California Los Angeles, Los Angeles, CA, ¹⁰Universität zu Köln, Köln, Germany, ¹¹Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, United Kingdom, ¹²UCL Division of Medicine, Royal Free Campus, London, United Kingdom, ¹³Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy, ¹⁴Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA
Background/Purpose: To date, there is lack of a uniform definition of systemic sclerosis related skin ulcer (SSc-skin ulcer) for use in clinical trials. Our group…
Abstract Number: 1871 • ACR/ARHP Annual Meeting 2016
Predicting Vascular Complications in Systemic Sclerosis: A Prospective Cohort Study
Christopher A. Mecoli¹, Ami A. Shah², Francesco Boin³, Fredrick M. Wigley⁴ and Laura K. Hummers¹, ¹Johns Hopkins University School of Medicine, Baltimore, MD, ²Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ³Rheumatology, University California San Francisco, San Francisco, CA, ⁴Rheum Div/Mason F Lord, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: Vascular disease is of fundamental importance in the pathogenesis of scleroderma. Two major vascular complications in scleroderma patients that cause substantial morbidity and mortality…

Abstracts tagged "scleroderma and ulcers"

Discriminant Validity and Reliability of World Scleroderma Foundation (WSF) Definition of Skin Ulcers in Systemic Sclerosis

Predicting Vascular Complications in Systemic Sclerosis: A Prospective Cohort Study